From: Genome-wide analysis of DNA methylation identifies S100A13 as an epigenetic biomarker in individuals with chronic (≥ 30 years) type 2 diabetes without diabetic retinopathy
Beta (95%CI)
P
cg02873163+12(%)
1.039(1.007,1.072)
0.017
cg02873163+2(%)
1.033(1.005,1.061)
0.020
cg02873163 (%)
1.034(1.006,1.063)
0.019
cg11343894+5(%)
1.025(1.000,1.051)
0.048
cg11343894(%)
1.026(1.000,1.053)
0.046